VEGF regulates the proliferation of acid-exposed alveolar lining epithelial cells

Ohwada, A.; Yoshioka, Y.; Iwabuchi, K.; Nagaoka, I.; Dambara, T.; Fukuchi, Y.
April 2003
Thorax;Apr2003, Vol. 58 Issue 4, p328
Academic Journal
Background: Acid induced pneumonitis resulting in acute respiratory distress syndrome (ARDS) is characterised by increased alveolar permeability and accumulation of neutrophils. It is hypothesised that vascular endothelial growth factor (VEGF) is involved in the development of lung oedema. Furthermore, lower levels of VEGF are detected in bronchoalveolar lavage fluid from patients with ARDS than from non-ARDS patients. We hypothesised that VEGF acts cytoprotectively and have investigated this possibility in vitro with A549 cells. Methods: A549 cells were incubated in 24 well culture dishes 24 hours before exposure to acid, then incubated with serum free medium containing various concentrations of HCl for 30 minutes at 37°C in 5% CO[sub 2]. The acidified medium was changed to normal complete medium; at specified incubation periods the supernatants were collected and the VEGF concentration measured and the number of adherent cells counted. Results: Proliferation of A549 cells and VEGF production were suppressed for at least 48 hours in HCl at a concentration of 50 mM. Restoration of cellular proliferation occurred following exogenous administration of VEGF (concentration of 1-250 ng/ml) and was inhibited by co-incubation with neutralising anti-VEGF antibody, indicating an interaction between VEGF molecules and A549 cells. Control cells were not influenced by administration of exogenous VEGF or anti-VEGF antibody. Treatment with neutralising anti-VEGF receptor (VEGFR) antibodies against VEGFR-1 and VEGFR-2 suppressed proliferation of acid exposed A549 cells but had no effect on control cells. Conclusions: Exogenous VEGF interacts with VEGFR-1 and VEGFR-2 on the surface and regulates the proliferation of injured alveolar lining epithelial cells in an autocrine or paracrine fashion.


Related Articles

  • Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: A potential role in diabetic nephropathy1. Senthil, Duraisamy; Choudhury, Goutam Ghosh; Mclaurin, Colby; Kasinath, Balakuntalam S. // Kidney International;Aug2003, Vol. 64 Issue 2, p468 

    Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: A potential role in diabetic nephropathy. Background. Vascular endothelial growth factor (VEGF) is an important determinant of ocular complications of diabetes. Its potential role in diabetic renal disease...

  • Role of vascular endothelial growth factor in the response to vessel injury. Arroyo, M. Victoria Alvarez; Carmelo, Carlos; Castilla, M. Angeles; Pancheco, Francisco R. Gonzalez; Martin, Olga; Arias, Javier // Kidney International Supplement;Dec1998, Issue 68, pS-7 

    Examines the role of vascular endothelial growth factor (VEGF) in pathological angionic processes; Effects of VEGF on vessel injury; Implications for the development of collateral circulation; Difference between the diverse angionic process.

  • Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours. Speirs, V; Atkin, S L // British Journal of Cancer;5/15/99, Vol. 80 Issue 5/6, p898 

    Production of vascular endothelial growth factor (VEGF) and expression of its receptors Flt-1 and KDR was determined in primary cultures of separated epithelial and stromal-enriched cultures derived from ten primary human breast carcinomas. By enzyme-linked immunosorbent assay, epithelial cells...

  • Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer. Shou, Y; Hirano, T; Gong, Y; Kato, Y; Yoshida, K; Ohira, T; Ikeda, N; Konaka, C; Ebihara, Y; Zhao, F; Kato, H // British Journal of Cancer;12/1/2001, Vol. 85 Issue 11, p1706 

    We attempted to investigate immunohistochemical expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PD-ECGF), c-erbB-2, matrix metalloproteinase-2 (MMP-2), and MMP-9 using surgical specimens of 119 non-small-cell lung...

  • Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Mukhopadhyay, Debabrata; Tsiokas, Leonidas // Nature;6/15/1995, Vol. 375 Issue 6532, p577 

    Investigates the signal transduction pathway involved in hypoxic induction of vascular endothelial growth factor (VEGF) expression. Inducement of tyrosine kinase cascade through hypoxia; Impact of expression of dominant-negative mutant form of c-Src or of Raf-1 on VEGF induction.

  • Anticancer drugs: Deadly cargo. Kirkpatrick, Peter // Nature Reviews Drug Discovery;Aug2002, Vol. 1 Issue 8, p568 

    Examines the role of vascular endothelial growth factor (VEGF) in angiogenesis. Fusion of toxin gelonin to VEGF; Reduction in tumor volume.

  • Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Mandl-Weber, Sonja; Cohen, Clemens D; Haslinger, Bettina; Kretzler, Matthias; Sitter, Thomas // Kidney International;Feb2002, Vol. 61 Issue 2, p570 

    Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells.. Background: Vascular endothelial growth factor (VEGF) was recently found in peritoneal effluents of peritoneal dialysis (PD) patients. It was suggested that human peritoneal mesothelial cells...

  • Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma. Lip, P.L.; Felmeden, D.C.; Blann, A.D.; Matheou, N.; Thakur, S.; Cunliffe, I.A.; Lip, G.Y.H. // British Journal of Ophthalmology;Nov2002, Vol. 86 Issue 11, p1299 

    Aim: To investigate plasma indices of vascular permeability (vascular endothelial growth factor, VEGF—also an index of angiogenesis, as well as the soluble receptor for VEGF, sFIt-1) and endothelial damage/dysfunction (von Willebrand factor, vWf) in glaucoma. Methods: Citrated plasma was...

  • VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Carmeliet, Peter // Nature Medicine;Oct2000, Vol. 6 Issue 10, p1102 

    Cites a study by R.J. Lee and colleagues, which found that unregulated, continuous delivery of vascular endothelial growth factor (VEGF) to the myocardium causes the formation of hemangiomas and death in mice. Dose-dependence of the biological effects of VEGF; Development of blood vessels in...


Read the Article


Sign out of this library

Other Topics